Our CEO Spoke at a Japan Medical Venture Association (JMVA) Study Session on the Dual-Use Market

On October 27, 2026, our CEO spoke at a study session and networking event held by the Japan Medical Venture Association (JMVA) at GLOBAL LIFESCIENCE HUB in Nihonbashi-Muromachi, Tokyo.

The event, titled "Exploring New Possibilities in Healthcare: Entering the Dual-Use (Military and Civilian) Market," focused on dual-use technologies in medicine.

Speakers from venture companies, the Japan Ground Self-Defense Force, the Ministry of Health, Labour and Welfare and other organizations presented their work and the challenges they face in the field, covering telemedicine, home-based and remote rehabilitation, antimicrobial resistance (AMR) countermeasures, and information sharing during patient transport.

CartaNova spoke on infection control and presented our work on AMR. In the panel discussion that followed, participants discussed how medical technologies needed in disasters and conflict can be developed and introduced so that they also benefit community healthcare in peacetime.

Topics included creating opportunities for clinical validation, cooperation between medical institutions, the Self-Defense Forces and government, regulation and procurement, and sustainable funding.

We sincerely thank JMVA for this valuable opportunity. CartaNova will continue to develop and deploy technologies that support infectious disease care and AMR countermeasures, in both peacetime and emergencies.